Clinical trial
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
NCT00478244 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00478244 |
|---|---|
| Title | Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa |
| Official title | Allogeneic Hematopoietic Cell Transplantation to Correct the Biochemical Defect and Create Tolerance to Donor Tissue in Subjects With Epidermolysis Bullosa |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Epidermolysis Bullosa |
| Intervention type | Drug, Procedure |
| Interventions | busulfan, cyclophosphamide, fludarabine phosphate, hematopoietic bone marrow transplantation |
| Enrollment | 7 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | May 24, 2007 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: